{
  "docId": "019de075-fb9a-714c-b35d-12bca943aee3",
  "docSlug": "2a9ec9aa90b640f79ff73c220b20ff7d",
  "documentTitle": "Immix Biopharma | Investor Presentation Deck | 57 slides",
  "authorId": "immix-biopharma",
  "authorName": "Immix Biopharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 52,
  "pageCount": 57,
  "prevPage": 51,
  "nextPage": 53,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 15,
  "notes": "The slide uses a numbered list format to present key value propositions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-fb9a-714c-b35d-12bca943aee3/52",
  "deckHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3",
  "deckJsonHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3.json",
  "deckAnchorHref": "/decks/019de075-fb9a-714c-b35d-12bca943aee3#slide-52",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.1,
        "x": 0.87,
        "y": 0.04
      },
      "kind": "image",
      "text": "IMMIX BIOPHARMA",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58431321-e528-405d-b52d-f3a88bb60c9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.8,
        "w": 0.96,
        "x": 0.02,
        "y": 0.0016
      },
      "kind": "list",
      "text": "1. First CAR-T in AL Amyloidosis... 2. Only CAR-T in BCMA-exposed... 3. First CAR-T Overcoming Neurotoxicity... 4. 72 NXC-201 CAR-T patients... 5. IMX-110 + PD-1 combination... 6. World-class team",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d2d2702f-9196-45e9-8f1d-c16cb5e661d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "IMMIX Biopharma Investment Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8b97c4df-1bbe-4c68-9eea-aa71e004317a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "17ce0b5b-f451-4638-babd-bc306aed4bbf",
      "evidence": "List of investment highlights",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "2fa93f92-cda8-438c-8fab-df727bc823b3",
      "evidence": "Numbered list of key investment highlights",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 57,
      "from": 37,
      "beatId": "4af44fe3-2e53-4cd0-baab-25c0bc9e9ebc",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The pipeline summary, team, and market opportunity slides provide satisfaction with the overall investment case.",
      "position": 7,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}